Clinical Trials Sponsored by ValenTx, Inc.

Total 35495 results

ValenTx, Inc.

Unknown

The ePass Clinical Trial for the Treatment of Obese Subjects (ePass)

Obesity

Argentina, Mexico
ValenTx, Inc.

Completed

Feasibility Trial of ValenTx Endo Bypass System

Obesity

Mexico
ValenTx, Inc.

Unknown

The ValenTx Endo Bypass System in Obese Subjects

Obesity

Canada, Mexico
ValenTx, Inc.

Completed

Feasibility Trial of ValenTx Endo Bypass System of the ValenTx Endo Bypass System in Obese Subjects

Obesity

Mexico
Valenta Pharm JSC

Not yet recruiting

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Heartburn | Acid-dependent Diseases of the Gastrointestinal Tract | Symptomatic Treatment of Gastric and Duodenal Ulcers

Russian Federation
Valenta Pharm JSC

Not yet recruiting

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

Viral Infection COVID-19

Russian Federation
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers

Infections

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy Volunteers

COVID-19 | Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19

COVID-19

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of Doxylamine + Pyridoxine, Film-coated, Enteric-soluble Tablets, and Diclectin, Delayed Release Tablets, in Healthy Volunteers

Nausea | Pregnancy Related

Russian Federation
Valenta Pharm JSC

Completed

A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders

Anxiety | Adjustment Disorders | Neurasthenia

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Vespireit, Sustained-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Valenta Pharm JSC

Recruiting

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Cholecystitis

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma

Pyoderma

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets

Healthy

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg

Cholecystitis

Russian Federation
Valenta Pharm JSC

Recruiting

Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin

Nausea

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

Influenza | Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Viral Respiratory Infection | Acute Viral Upper Respiratory Infections

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Study of the Effect of Food Intake on the Bioavailability of XC8 10 mg Film-coated Tablets

Healthy

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Valenta Pharm JSC

Completed

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection | Flu | Viral Infection

Russian Federation
Valentis

Completed

Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease

Peripheral Vascular Disease

United States
Valentis

Completed

Trial of VLTS-589 in Subjects With Intermittent Claudication

Intermittent Claudication | Peripheral Vascular Disease

United States
Valent Technologies, LLC

Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Ewing Sarcoma | Medulloblastoma | Neuroblastoma | Solid Tumors | Rhabdomyosarcoma | Hepatoblastoma

United States
Valeant Pharmaceuticals

Unknown

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Acne Vulgaris
Valeant Pharmaceuticals

Completed

Thermage CPT for Treatment of Facial and Neck Laxity

Skin Aging

United States
Valeant Pharmaceuticals

Unknown

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Valeant Pharmaceuticals

Unknown

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Acne Vulgaris
Valeant Pharmaceuticals

Unknown

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Acne Vulgaris
Bausch Health Americas, Inc.
Valeant Russia, LLC

Completed

Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy (NMRUS)

Vertebrogenic Radiculopathy L5, S1

Russian Federation
Klinik Valens

Recruiting

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis (TIME)

Multiple Sclerosis, Chronic Progressive | High-Intensity Interval Training | Motor Symptoms

Switzerland
Klinik Valens

Unknown

Changes in Physical Activity in All Day Life in People With MS Before and After Rehabilitation

Rehabilitation

Switzerland
Klinik Valens

Completed

Rehabilitation in Multiple Sclerosis - Sometimes Too Much?

Multiple Sclerosis

Switzerland
Klinik Valens

Recruiting

Augmented Reality Treadmill Training in Patients With Parkinson's Disease (Falls_in_PD)

Parkinson Disease | Fall

Switzerland
Klinik Valens

Active, not recruiting

Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up

Oncologic Disorders

Switzerland
Klinik Valens

Completed

Shared Decision Making in Physical Therapy: a Cross-sectional Observational Study

Shared Decision Making

Switzerland
Klinik Valens

Completed

Usability and Acceptance of Exergames Among Elderly People and Physiotherapists - a Mixed Method Approach

Mobility Limitation

Switzerland
Klinik Valens

Completed

Is Inpatient Rehabilitation Effective for Very Old Patients?

Musculoskeletal Diseases | Elderly Patients | Activity, Motor

Switzerland
Klinik Valens

Completed

Rehabilitation After Covid19-Clinical Results and Predictive Factors

Covid19

Switzerland
Klinik Valens

Active, not recruiting

High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study

Rehabilitation | Oncology | Post-Operative Condition | Deconditioning After Acute Hospital

Switzerland
Klinik Valens

Unknown

Towards Better Understanding of FCE Performance in Different Societal Contexts (FCEinternat)

Musculoskeletal Diseases

3

Subscribe